Company news: Par Pharmaceutical; Gilead
July 16 2012
Par Pharmaceutical is going private, selling to TPG for $1.9 billion in cash.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.